Latest Breaking News On - பார்மா சேவைகள் பிரிவு - Page 10 : comparemela.com

NeoGenomics, Inc.: NeoGenomics To Participate In The Virtual Raymond James 42nd Annual Institutional Investors Conference FT. MYERS, FL / ACCESSWIRE / March 1, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that Chief Financial Officer Kathryn McKenzie and Doug Brown, Chief Strategy and Corporate Development Officer will be presenting at the Virtual Raymond James 42 nd Annual Institutional Investors Conference 2021, on Wednesday, March 3, 2021 at 10:50am ET. The presentation will be webcast live and accessible online via the investors section of the Company s website, www.neogenomics.com. About NeoGenomics, Inc. NeoGenomics, Inc. specializes in cancer genetics testing and information services. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company s Pharma

Fort myersUnited statesSan diegoAliso viejoCharlie eidsonKathryn mckenzieRaymond jamesDoug brownNeogenomics incCompany pharma services divisionCompany annual report on formWhile the companyCompany overview presentationCorporate developmentChief financial officer kathryn mckenzieChief strategy